Live Breaking News & Updates on Diseases Conference

Stay updated with breaking news from Diseases conference. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Taurx To Present Two-Year Data From Phase III Trial Of HMTM In Alzheimer's Disease At The AD/PDTM 2024 Conference In Marc...

Taurx To Present Two-Year Data From Phase III Trial Of HMTM In Alzheimer's Disease At The AD/PDTM 2024 Conference In Marc...
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Serge Gauthier , Claude Wischik , Henrik Zetterberg , Alistair Burns , David Watson , Taurx Pharmaceuticals Ltd , Diseases Conference , Executive Chairman , Professor Henrik Zetterberg , Professor Alistair Burns , Professor Claude Wischik , Professor Wischik ,

TOKYO Nikkei and the Financial Times on Monday hosted the tenth Nikkei FT Communicable Diseases Conference in Tokyo. The three-day conference ....

Tedros Adhanom Ghebreyesus , World Health Organization , Financial Times , Diseases Conference ,

GenSight Biologics to Present at Upcoming 2022 Medical Conferences

GenSight Biologics to Present at Upcoming 2022 Medical Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Comunidad Autonoma De Cataluna , Clothilde Caillet , Magali Taiel , James Palmer , Gensight Biologics Euronext , Guillaume Van Renterghem , Jeanene Timberlake , Institut Catal , Lorena Castillo , Gensight Biologics , Patrick Yu , European Association For Vision , University Of Cambridge , Eye Research , Corporate Communications , University Of Pittsburgh School Medicine , American Academy Of Ophthalmology , Sight Biologics , American Academy , Annual Meeting , Bilateral Gene Therapy , Leber Hereditary Optic Neuropathy , Patrick Yu Wai Man , Principal Investigator ,

Inhibikase Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Period Activity

/PRNewswire/ Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing therapeutics to modify. ....

United States , Miltonh Werner , Alex Lobo , Milton Werner , Company Phase , Inhibikase Therapeutics Inc , Company Contact , Prnewswire Inhibikase Therapeutics Inc , Inhibikase Or Company , European Union , Sternir Inc , Chief Executive Officer , Chronic Myelogenous Leukemia , Multiple Systems Atrophy , Upcoming Milestones , Key Opinion Leaders , Diseases Conference , Central Nervous , New Drug , Multiple System Atrophy , Expenses Selling , Abelson Tyrosine Kinase , Private Securities Litigation Reform Act , Months Ended March , Inhibikase Therapeutics ,

Inhibikase Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Period Activity

Company to host conference call and webcast on Tuesday, May 17, 2022, at 8:00am ETBOSTON and ATLANTA, May 16, 2022 /PRNewswire/ Inhibikase Ther. ....

United States , Miltonh Werner , Alex Lobo , Milton Werner , Company Phase , Inhibikase Therapeutics Inc , Company Contact , Prnewswire Inhibikase Therapeutics Inc , Inhibikase Or Company , European Union , Sternir Inc , Chief Executive Officer , Chronic Myelogenous Leukemia , Multiple Systems Atrophy , Upcoming Milestones , Key Opinion Leaders , Diseases Conference , Central Nervous , New Drug , Multiple System Atrophy , Expenses Selling , About Inhibikase , Abelson Tyrosine Kinase , Private Securities Litigation Reform Act , Months Ended March ,